Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro

BACKGROUND: Neuroblastoma (NB) is a devastating disease. Despite recent advances in the treatment of NB, about 60% of high-risk NB will have relapse and therefore long-term event free survival is very minimal. We have reported that targeting glycogen synthase kinase-3 (GSK-3) may be a potential stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunnimalaiyaan, Selvi, Schwartz, Victoriana K., Jackson, Iris Alao, Clark Gamblin, T., Kunnimalaiyaan, Muthusamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948712/
https://www.ncbi.nlm.nih.gov/pubmed/29751783
http://dx.doi.org/10.1186/s12885-018-4474-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948712/
https://www.ncbi.nlm.nih.gov/pubmed/29751783
http://dx.doi.org/10.1186/s12885-018-4474-7

Ejemplares similares